These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 8730754)
1. Pharmacological profile of TP-680, a new cholecystokininA receptor antagonist. Akiyama T; Tachibana I; Hirohata Y; Shirohara H; Yamamoto M; Otsuki M Br J Pharmacol; 1996 Apr; 117(7):1558-64. PubMed ID: 8730754 [TBL] [Abstract][Full Text] [Related]
2. Pharmacologic profile of TS-941, a new benzodiazepine derivative cholecystokinin-receptor antagonist, in in vitro isolated rat pancreatic acini. Tashiro M; Hirohata Y; Kihara Y; Akiyama T; Otsuki M Pancreas; 1999 Mar; 18(2):156-64. PubMed ID: 10090413 [TBL] [Abstract][Full Text] [Related]
3. Pharmacological profile of T-0632, a novel potent and selective CCKA receptor antagonist, in vitro. Taniguchi H; Yazaki N; Endo T; Nagasaki M Eur J Pharmacol; 1996 May; 304(1-3):147-54. PubMed ID: 8813597 [TBL] [Abstract][Full Text] [Related]
4. Characterization of a new cholecystokinin receptor antagonist FK480 in in vitro isolated rat pancreatic acini. Akiyama T; Otsuki M Pancreas; 1994 May; 9(3):324-31. PubMed ID: 8022754 [TBL] [Abstract][Full Text] [Related]
5. Pharmacological profile of a new serine derivative cholecystokinin receptor antagonist TP-680 on pancreatic, biliary and gastric function. Tachibana I; Kanagawa K; Yamamoto Y; Otsuki M J Pharmacol Exp Ther; 1996 Dec; 279(3):1404-12. PubMed ID: 8968365 [TBL] [Abstract][Full Text] [Related]
6. [Inhibitory effect of a new proglumide derivative, loxiglumide, on CCK action in isolated rat pancreatic acini]. Fujii M; Otsuki M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S Nihon Shokakibyo Gakkai Zasshi; 1989 Jan; 86(1):77-82. PubMed ID: 2471851 [TBL] [Abstract][Full Text] [Related]
7. Characterization of a new diphenylpyrazolidinone cholecystokinin antagonist in vitro isolated rat pancreatic acini. Akiyama T; Tachibana I; Otsuki M Int J Pancreatol; 1993 Oct; 14(2):167-73. PubMed ID: 7506744 [TBL] [Abstract][Full Text] [Related]
8. Loxiglumide. A new proglumide analog with potent cholecystokinin antagonistic activity in the rat pancreas. Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S Dig Dis Sci; 1989 Jun; 34(6):857-64. PubMed ID: 2470557 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological profile of T-0632, a novel potent and selective CCKA receptor antagonist, in vivo. Taniguchi H; Yazaki N; Yomota E; Shikano T; Endo T; Nagasaki M Eur J Pharmacol; 1996 Sep; 312(2):227-33. PubMed ID: 8894600 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological profile of FK480, a novel cholecystokinin type-A receptor antagonist: comparison to loxiglumide. Ito H; Sogabe H; Nakarai T; Sato Y; Tomoi M; Kadowaki M; Matsuo M; Tokoro K; Yoshida K J Pharmacol Exp Ther; 1994 Feb; 268(2):571-5. PubMed ID: 7509389 [TBL] [Abstract][Full Text] [Related]
11. Effects of a new proglumide analogue CR 1392 on pancreatic exocrine secretion in the rat. Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S Digestion; 1989; 42(2):61-9. PubMed ID: 2475379 [TBL] [Abstract][Full Text] [Related]
12. Characterization of a new CCK antagonist, L364,718: in vitro and in vivo studies. Louie DS; Liang JP; Owyang C Am J Physiol; 1988 Sep; 255(3 Pt 1):G261-6. PubMed ID: 2458681 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of two cholecystokinin-receptor antagonists, loxiglumide and L-364,718, on the pancreatic secretory response to intraduodenal tryptophan in dogs. Niebergall-Roth E; Teyssen S; Wetzel D; Hartel M; Beglinger C; Riepl RL; Singer MV Scand J Gastroenterol; 1996 Jul; 31(7):723-32. PubMed ID: 8819225 [TBL] [Abstract][Full Text] [Related]
14. Biochemical and pharmacological profiles of loxiglumide, a novel cholecystokinin-A receptor antagonist. Fukamizu Y; Nakajima T; Kimura K; Kanda H; Fujii M; Saito T; Kasai H Arzneimittelforschung; 1998 Jan; 48(1):58-64. PubMed ID: 9522034 [TBL] [Abstract][Full Text] [Related]
15. CCK antagonists reveal that CCK-8 and JMV-180 interact with different sites on the rat pancreatic acinar cell CCKA receptor. Yule DI; Williams JA Peptides; 1994; 15(6):1045-51. PubMed ID: 7527529 [TBL] [Abstract][Full Text] [Related]
16. A new CCK-B/gastrin receptor antagonist acts as an agonist on the rat pancreas. Koop I; Eissele R; Richter S; Patberg H; Meyer F; Mössner J; Arnold R; Koop H Int J Pancreatol; 1994 Jun; 15(3):215-22. PubMed ID: 7523549 [TBL] [Abstract][Full Text] [Related]
17. Peripheral biological activity of SR 27897: a new potent non-peptide antagonist of CCKA receptors. Gully D; Fréhel D; Marcy C; Spinazzé A; Lespy L; Neliat G; Maffrand JP; Le Fur G Eur J Pharmacol; 1993 Feb; 232(1):13-9. PubMed ID: 7681406 [TBL] [Abstract][Full Text] [Related]
18. Pharmacological evaluation of IQM-95,333, a highly selective CCKA receptor antagonist with anxiolytic-like activity in animal models. Ballaz S; Barber A; Fortuño A; Del Río J; Martin-Martínez M; Gómez-Monterrey I; Herranz R; González-Muñiz R; García-López MT Br J Pharmacol; 1997 Jun; 121(4):759-67. PubMed ID: 9208145 [TBL] [Abstract][Full Text] [Related]
19. Combined dose-ratio analysis of cholecystokinin receptor antagonists, devazepide, lorglumide and loxiglumide in the guinea-pig gall bladder. Bishop LA; Gerskowitch VP; Hull RA; Shankley NP; Black JW Br J Pharmacol; 1992 May; 106(1):61-6. PubMed ID: 1504732 [TBL] [Abstract][Full Text] [Related]
20. CCK receptor antagonist loxiglumide alters uptake of CCK in perfused liver and pancreatic acini of the rat. Beckh K; Göke R; Ruff W; Koop I; Arnold R; Adler G Digestion; 1991; 48(2):98-103. PubMed ID: 1868975 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]